Woodle, Holman, Hanaway et al [provisional name] (Alemtuzumab, thymoglobulin and basiliximab in renal transplantation [provisional name])
ID: 5bd4e66f7aaac805465b1d7e
3 Documentos
Cerrar
3 Referencias ( articles) loading Revertir Estudificar

Estudio primario

No clasificado

12 month results of a multicenter, randomized trial comparing three induction agents (Alemtuzumab, Thymoglobulin and Basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation

Revista American Journal of Transplantation
Año 2008
Cargando información sobre las referencias

Estudio primario

No clasificado

12 month results of a multicenter, randomized trial comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation

Revista Transplantation
Año 2008
Cargando información sobre las referencias

Estudio primario

No clasificado

Immune cell activation comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation

Revista Transplantation
Año 2008
Cargando información sobre las referencias